The First Line of Intra-Abdominal Metastatic Attack: Breaching the Mesothelial Cell Layer

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-11-0117
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Immunotherapy for the First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

Effectiveness of First-Line Treatments in Metastatic Squamous Non-Small-Cell Lung Cancer

Current Oncology
Oncology
2019English

Metastatic Small Cell Carcinoma of the Prostate in an Octogenarian With Significant Response to First-Line Chemotherapy

Hematology & Medical Oncology
2017English

The First Case of Huge Amebic Intra-Abdominal Tumor With Asymptomatic Amebic Colitis

Surgical Case Reports
2015English

Survival Benefits of Second-Line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma

Pathology and Oncology Research
MedicineForensic MedicinePathologyOncologyCancer Research
2020English

Treatment of Metastatic Germ Cell Tumors With Etoposide and Cisplatin as First Line Chemotherapy

Japanese Journal of Urology
Urology
2002English

Cetuximab in First Line Treatment of Metastatic Colorectal Cancer

Farmeconomia. Health economics and therapeutic pathways
2012English

Intra-Abdominal Infection Combined With Intra-Abdominal Hypertension Aggravates the Intestinal Mucosal Barrier Dysfunction

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2018English

Do Tyrosine Kinase Inhibitors Lose Favor in Treatment of First-Line Metastatic Renal Cell Carcinoma?

Future Oncology
MedicineCancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy